News Snapshot:
Subscribe now! Get as A popular Chinese eHealth platform that criticizes the government’s COVID policies, denounces a government-approved Covid-19 herbal treatment, has been censured by the government for “violating applicable legislation and regulations. “ DXY, which counts tech giant Tencent among its investors and manages a multitude of health-related services, has in the past questioned the use of classic Chinese medicine Lianhua Qingwen as a remedy for covid-19. This remedy was advertised as opposed to fever and sore throat. Critics, among others, have sunk the pharmaceutical giant’s shares. China accepted the mixture, which consists of ingredients such as honeysuckle and...
